Connective Issue #7

MIB News
Connective Issue #7

Volume 7 | March 8, 2023 | View in Browser

The Power of Patient Voices

As we thank our 2022 MIB Agents Junior Advisory Board, and welcome our 2023 members, we are reminded about how critical patient perspective is for improving osteosarcoma clinical care. Our Junior Advisory Board, a group of young adults who either have lost a sibling to osteosarcoma or are OsteoWarriors themselves, is in many ways our north star, not only for MIB Agents initiatives and programs, but for our community, like pharmaceutical companies seeking patient input for communications and clinical trials. Patients and their families are also key partners in our OutSmarting grant process, not only funding the grants, but participating side by side with our scientific peer reviewers to provide input on patient impact.  When MIB Agents recently visited our 2022 OutSmarting recipients in Denver and Atlanta, we conveyed the significance and urgency of the funded research by shining a light on the patients and families who are in crucial need of new treatments and have been impacted by this disease. By opening up the conversation to patients and making room for their voices, the osteosarcoma community is making huge strides. Patients can make their voice heard by participating in a global patient survey on bone sarcoma research priorities. They might not be able to talk, but dogs can make an impact too through our OutBarking Osteosarcoma fundraiser. And please check out the DOGBONe team is this issue, about how they are giving voice to their canine patients by collaborating on samples and canine osteosarcoma research.

With hope,


Save The Date


Register Now for FACTOR 2023!

Join us June 22-24 at the Whitley Hotel in Atlanta for the 6th Annual FACTOR conference!

Register by March 15th to take advantage of the Early Bird discount! 
Apply for a Family Fund FACTOR Travel Award - Due April 7th

OutBarking Osteosarcoma

The incidence rate of osteosarcoma is 10-50x higher in dogs than in humans. Groundbreaking osteosarcoma research in dogs will translate to better treatments for kids.  OutBark Osteosarcoma with us!  Order a fashion statement bandana for your doggie, snap a photo of your doggie rocking the bandana, and encourage your friends and family to vote for who wore it best! Voting ends on March 17 and winners will be announced on March 23 on National Puppy Day! Learn More

Get Your Bandana

Vote for Your Favorite Pup

Meet our 2023 Junior Advisory Board

Thank you to our 2022 Junior Advisory Board!
Welcome to our 2023 Junior Advisory Board!

MIB Agents in Atlanta and Denver

MIB Agents with Michael Leibowitz, MD, PhD and team at the University of Colorado at Anschutz
MIB Agents with Dan Regan, DVM, PhD, DACVP and team at the Colorado State University Flint Animal Cancer Center
MIB Agents and Count Me In with Jason Yustein, MD, PhD at Children's Healthcare of Atlanta

Canadian Researchers Team Up to Fight Canine Osteosarcoma

Meet the DOGBONe group at the University of Guelph Ontario Veterinary College. Anthony J. Mutsaers DVM, PhD, DACVIM Oncology, Associate Professor at OVC shares with us the focus of the DOGBONe group, how the group came together, and how the group has evolved into an osteosarcoma multidisciplinary research team that shares samples, and is studying novel therapeutics for osteosarcoma.

Read More About DOGBONe

Career Connection

If you have a job posting and you would like it included here, please email


OsteoBites Webinar Series

March 9 | Kelly Bailey, MD, PhD  Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks
March 16 | osTEAo AYA Podcast Navigating Campus: Limb-Salvage and Amputation Patient Perspectives
March 23 | Erin Murphy, MD SBRT and SRS for Sarcoma
March 30 | Claudia Benavente, PhD UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression

Watch Past Episodes and See the Upcoming Schedule

Osteosarcoma Tumor Board

Open to researchers and clinicians

A virtual tumor review board for osteosarcoma, TURBO is open to global clinicians or researchers with an interest in osteosarcoma.  Patients and families are welcome to ask their oncologists to present a case on their behalf.  Join TURBO to request an invite or submit a case.

Next meeting: March 8th at 5pm ET

Next meeting: May 10th at 5pm ET


Osteosarcoma in the News


Ambassador Agents Training at FACTOR 2023

MIB Agents has assisted many OS Warriors and their families by carefully matching them with osteosarcoma survivors and their families. We are always ready to help OS Warriors and their families to find an Ambassador Agent, who are devoted to helping their peers navigate life through osteosarcoma.  Our next in-person training session for Ambassadors will take place at the Whitley Hotel in Atlanta on June 21st, the day before the official start of the MIB Agents FACTOR23 conference in Atlanta.

To learn more or to request an Ambassador Agent, contact

Sign Up for Ambassador Agent Training at FACTOR23


Patient Survey on Bone Sarcoma Research Opportunities

The patients and parents group in the FOSTER (Fight OSteosarcoma Through European Research) consortium are undertaking the first-ever global survey for bone sarcoma patients. Take the survey to have your voice heard and share your experiences and research priorities.  The survey is open to all global bone sarcoma patients, survivors, and caregivers.

Take the Survey

Access the MIB Agents clinical trials search powered by Antidote to find a clinical trial for osteosarcoma in 60 seconds.

If you have a trial that is currently enrolling osteosarcoma patients and you would like it included here, please email

All MIB Agents programs are free of charge, thanks to our generous donors who Make it Better.


Other blog posts